These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1053237)

  • 1. The effect of formaldehyde on the toxicity and potency of pertussis vaccine.
    Gottshall RY; Nelson E; Angela F; Anderson G
    Health Lab Sci; 1975 Jan; 12(1):35-40. PubMed ID: 1053237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the toxicity of the pertussis component of the Di-Te-Per vaccine].
    Gołobów M; Kardymowicz B; Kudelski Z; Rymkiewicz D; Sawicki J
    Med Dosw Mikrobiol; 1986; 38(1):9-14. PubMed ID: 2423821
    [No Abstract]   [Full Text] [Related]  

  • 6. The stability of bacterial vaccines at elevated temperatures.
    Stainer DW; Hart FE
    Dev Biol Stand; 1978; 41():249-53. PubMed ID: 753653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
    Redhead K; Sesardic D; Yost SE; Attwell AM; Watkins J; Hoy CS; Plumb JE; Corbel MJ
    Biologicals; 1994 Dec; 22(4):339-45. PubMed ID: 7779360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of rat-paw oedema tests for assessing reactivity of B. pertussis-containing combined vaccines.
    Průchova J; Karel J; Vrána M; Elis J; Blazek Z
    Dev Biol Stand; 1986; 65():177-83. PubMed ID: 2881822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
    Horiuchi Y; Takahashi M; Asada S; Ishida S
    Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple chemically defined medium for the production of phase I Bordetella pertussis.
    Stainer DW; Scholte MJ
    J Gen Microbiol; 1970 Oct; 63(2):211-20. PubMed ID: 4324651
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the potency of the pertussis component in DPT vaccine produced in stationary culture and by fermentation].
    Galicia O; Villalva H; Pérez A; Pérez S; Medina A
    Salud Publica Mex; 1981; 23(6):607-11. PubMed ID: 6278658
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse toxicity of triple vaccine (DTP) mixed with poliomyelitis vaccine.
    Gottshall RY; Anderson GR; Nelson EA; Wilcox KR
    Mich Med; 1969 Feb; 68(3):131-4. PubMed ID: 5763453
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.